Federal grants to Redbud Labs, Inc.
Redbud Labs, Inc. in Research Triangle Park, North Carolina received $14.6 million in federal grants from fiscal 2021 to 2025, across 11 awards. Its largest program was Biomedical Research and Research Training, with $7.6 million. In fiscal 2025 it was awarded $3.6 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$14.6 million
- Awards11
- Awarded in FY 2025$3.6 million
- Largest award$2.5 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 3 | $881,682 |
| FY 2022 | 6 | $3.8 million |
| FY 2023 | 3 | $2.9 million |
| FY 2024 | 3 | $3.5 million |
| FY 2025 | 3 | $3.6 million |
Programs that fund Redbud Labs, Inc.
| Program | Awards | Amount |
|---|---|---|
| Biomedical Research and Research Training | 5 | $7.6 million |
| Allergy and Infectious Diseases Research | 3 | $4.5 million |
| Mental Health Research Grants | 1 | $1.9 million |
| Discovery and Applied Research for Technological Innovations to Improve Human Health | 1 | $304,329 |
| Engineering | 1 | $301,304 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 10 | $14.3 million |
| National Science Foundation | 1 | $301,304 |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Improving extraction success of ffpe samples with automated and reliable microfluidic sample preparation - abstract genomic sequencing data is suitable for informing clinical decisions and advancing precision medicine. While fresh-frozen tissues are the gold standard for next-generation sequencing, | Biomedical Research and Research Training | July 3, 2024 | $2.5 million |
| System for unitary automation of library preparation - abstract genomic epidemiology is crucial to outbreak surveillance and response. Sequencing data lets us track virus evolution in real time to characterize transmission chains, identify emerging variants, and predict future spread. This informati | Biomedical Research and Research Training | May 20, 2024 | $2.5 million |
| A modular platform for infectious disease surveillance at point-of-need. | Allergy and Infectious Diseases Research | July 14, 2021 | $2.3 million |
| Rapid point-of-care molecular test for hcv vl - abstract chronic hepatitis c virus (HCV) infection is a hidden public health problem, due to ineffective disease testing and surveillance strategies. Testing for hcv is two-step, with patients initially screened for hcv antibodies, followed with an rna | Allergy and Infectious Diseases Research | April 2, 2024 | $2.0 million |
| Enhanced mdx: a computational model to optimize pre-analytical pathogen isolation from whole blood - abstract microscale simulations have been applied to a number of complex microfluidic systems and biological applications, but existing methods are limited in the scale and scope of problems that are | Biomedical Research and Research Training | June 21, 2022 | $2.0 million |
| Point-of-care HIV viral load system using rpa and mxr - abstract the most accurate way to monitor the efficacy of antiretroviral therapy is through nucleic acid amplification tests (NAATS) that directly measure HIV rna (viral load). In the developing and developed world these tests are primarily con | Mental Health Research Grants | July 13, 2022 | $1.9 million |
| Mems-enhanced solid-phase isothermal amplification for rapid, multiplexed molecular diagnostics - abstract rna viruses are responsible for substantial morbidity and mortality worldwide, from HIV to influenza, to coronavirus. As the clinical presentation for disease may be similar or asymptomatic, ac | Discovery and Applied Research for Technological Innovations to Improve Human Health | May 23, 2022 | $304,329 |
| Sbir phase II: microfilm to enable enhanced mixing in low-resource diagnostics | Engineering | October 6, 2020 | $301,304 |
| System for unitary automation of library preparation - abstract genomic epidemiology is crucial to outbreak surveillance and response. Sequencing data lets us track virus evolution in real time and thus characterize transmission chains, identify emerging variants, and predict future spread. This inf | Biomedical Research and Research Training | February 17, 2022 | $292,788 |
| Rapid point-of-care molecular test for hcv vl - abstract hepatitis c, the inflammatory liver disease caused by hepatitis c virus (HCV), claims approximately 400,000 lives each year from secondary hepatocellular carcinoma and cirrhosis-induced liver failure. Direct-acting antiviral agents can cure > | Allergy and Infectious Diseases Research | August 30, 2021 | $288,729 |
Questions people ask
How much federal grant money does Redbud Labs, Inc. get?
$14.6 million in 11 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Redbud Labs, Inc. the most?
The Department of Health and Human Services, with $14.3 million in 10 awards. The National Science Foundation follow.
What is Redbud Labs, Inc.'s largest federal grant?
$2.5 million under Biomedical Research and Research Training, with its first action in the period on July 3, 2024. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Redbud Labs, Inc.?
Its largest are Biomedical Research and Research Training, Allergy and Infectious Diseases Research and Mental Health Research Grants.
Other grant recipients in Research Triangle Park
- Research Triangle Institute
- Epicypher, Inc.
- T3D Therapeutics, Inc.
- Altis Biosystems, Inc.
- Dignify Therapeutics, LLC
- Zymtronix Catalytic Systems, Inc.
- 21MEDTECH LLC
- North Carolina Biotechnology Center
Largest federal grant recipients in North Carolina · Federal grants in North Carolina